Showing results (131-140 of 190) with videos related to
Sort By:
Pageof 19
Respirology (Carlton, Vic.)|June 23, 2021
COVID-19: Histopathological correlates of imaging patterns on chest computed tomographyAzar Kianzad, Lilian J Meijboom, Esther J Nossent, et al.ERJ Open Research|July 13, 2026
ERS Congress 2025: highlights from the Pulmonary Vascular Diseases AssemblyBrandon Budhram, Léon Genecand, Katarina Zeder, et al.ERJ Open Research|May 19, 2022
Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertensionDieuwertje Ruigrok, M Louis Handoko, Lilian J Meijboom, et al.Circulation|January 17, 2015
Endothelial-to-mesenchymal transition in pulmonary hypertensionBenoît Ranchoux, Fabrice Antigny, Catherine Rucker-Martin, et al.Pulmonary Circulation|May 2, 2023
Automated quantification of the pulmonary vasculature in pulmonary embolism and chronic thromboembolic pulmonary hypertensionZhiwei Zhai, Gudula J A M Boon, Marius Staring, et al.American Journal of Respiratory Cell and Molecular Biology|August 7, 2020
DNGR1-Cre-mediated Deletion of Tnfaip3/A20 in Conventional Dendritic Cells Induces Pulmonary Hypertension in MiceThomas Koudstaal, Jennifer A C van Hulst, Tridib Das, et al.The European Respiratory Journal|March 21, 2024
Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre studyJulien Grynblat, Harm Jan Bogaard, Mélanie Eyries, et al.Cell Reports|September 21, 2018
Stiffness-Induced Endothelial DLC-1 Expression Forces Leukocyte Spreading through Stabilization of the ICAM-1 AdhesomeLilian Schimmel, Miesje van der Stoel, Carmela Rianna, et al.Journal of the National Cancer Institute|August 21, 2023
Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trialNicole E Billingy, Vashti N M F Tromp, Neil K Aaronson, et al.Trials|February 17, 2022
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19Leila Atmowihardjo, Job R Schippers, Imke H Bartelink, et al.Pageof 19